Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Failure | 52 | 2024 | 11848 | 5.080 |
Why?
|
Palliative Care | 32 | 2024 | 3607 | 4.960 |
Why?
|
Hospice Care | 14 | 2022 | 692 | 4.850 |
Why?
|
Hospices | 10 | 2021 | 256 | 3.740 |
Why?
|
Rural Population | 10 | 2022 | 2268 | 2.400 |
Why?
|
Urban Population | 5 | 2021 | 2022 | 1.760 |
Why?
|
Terminal Care | 8 | 2022 | 1758 | 1.730 |
Why?
|
Cardiovascular Diseases | 21 | 2024 | 15760 | 1.510 |
Why?
|
Heart-Assist Devices | 5 | 2023 | 1291 | 1.440 |
Why?
|
Shock, Cardiogenic | 3 | 2021 | 734 | 1.400 |
Why?
|
Translating | 4 | 2022 | 148 | 1.300 |
Why?
|
United States Food and Drug Administration | 4 | 2024 | 1677 | 1.230 |
Why?
|
Health Expenditures | 11 | 2023 | 2362 | 1.190 |
Why?
|
Mortality | 6 | 2022 | 2916 | 1.180 |
Why?
|
Echocardiography, Transesophageal | 11 | 2014 | 1108 | 1.030 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2022 | 2128 | 1.010 |
Why?
|
Death | 3 | 2021 | 678 | 1.010 |
Why?
|
United States | 55 | 2024 | 72448 | 1.000 |
Why?
|
Quality of Life | 16 | 2024 | 13308 | 0.990 |
Why?
|
Communication Barriers | 3 | 2022 | 415 | 0.950 |
Why?
|
Heart Diseases | 6 | 2022 | 2809 | 0.930 |
Why?
|
Prescription Drugs | 3 | 2023 | 630 | 0.920 |
Why?
|
Renal Insufficiency | 2 | 2022 | 820 | 0.910 |
Why?
|
Mitral Valve | 7 | 2013 | 1486 | 0.890 |
Why?
|
Echocardiography, Three-Dimensional | 7 | 2013 | 613 | 0.870 |
Why?
|
Humans | 156 | 2024 | 760613 | 0.860 |
Why?
|
Myocardial Ischemia | 3 | 2023 | 2164 | 0.850 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.800 |
Why?
|
Pharmacies | 1 | 2023 | 164 | 0.780 |
Why?
|
Drug Labeling | 1 | 2024 | 251 | 0.760 |
Why?
|
Food Labeling | 1 | 2024 | 180 | 0.760 |
Why?
|
Dyslipidemias | 3 | 2018 | 895 | 0.750 |
Why?
|
Stroke Volume | 7 | 2024 | 5523 | 0.740 |
Why?
|
Home Care Services | 4 | 2020 | 654 | 0.730 |
Why?
|
Referral and Consultation | 6 | 2022 | 3598 | 0.720 |
Why?
|
Humanism | 1 | 2021 | 87 | 0.710 |
Why?
|
Mitral Valve Insufficiency | 5 | 2013 | 1419 | 0.690 |
Why?
|
Dementia, Vascular | 1 | 2020 | 125 | 0.680 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2022 | 3332 | 0.680 |
Why?
|
Cardiology | 4 | 2024 | 1723 | 0.680 |
Why?
|
Poliomyelitis | 2 | 2011 | 94 | 0.660 |
Why?
|
Healthcare Disparities | 5 | 2024 | 3386 | 0.660 |
Why?
|
Advance Care Planning | 3 | 2021 | 697 | 0.650 |
Why?
|
Drug Costs | 4 | 2023 | 1185 | 0.640 |
Why?
|
Myocardial Infarction | 6 | 2022 | 11890 | 0.630 |
Why?
|
Suicide, Assisted | 1 | 2019 | 69 | 0.620 |
Why?
|
Aged | 51 | 2024 | 169143 | 0.620 |
Why?
|
Needs Assessment | 2 | 2021 | 1139 | 0.600 |
Why?
|
Respiration Disorders | 1 | 2021 | 368 | 0.590 |
Why?
|
Health Care Costs | 6 | 2023 | 3258 | 0.590 |
Why?
|
Health Facilities | 1 | 2022 | 578 | 0.580 |
Why?
|
Hospital Administration | 1 | 2021 | 355 | 0.580 |
Why?
|
Drug Utilization | 2 | 2020 | 1195 | 0.570 |
Why?
|
Disclosure | 1 | 2023 | 738 | 0.560 |
Why?
|
Cardiotonic Agents | 1 | 2019 | 546 | 0.530 |
Why?
|
Congresses as Topic | 1 | 2021 | 805 | 0.530 |
Why?
|
Donor Selection | 1 | 2018 | 228 | 0.520 |
Why?
|
Chronic Disease | 5 | 2024 | 9288 | 0.520 |
Why?
|
Stroke | 6 | 2022 | 9952 | 0.520 |
Why?
|
Health Personnel | 2 | 2019 | 3310 | 0.490 |
Why?
|
Laboratories, Hospital | 1 | 2016 | 193 | 0.490 |
Why?
|
Measles | 2 | 2015 | 185 | 0.490 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2018 | 379 | 0.490 |
Why?
|
Health Services Accessibility | 5 | 2024 | 5397 | 0.490 |
Why?
|
Disease Outbreaks | 3 | 2015 | 1758 | 0.480 |
Why?
|
Probability | 2 | 2021 | 2475 | 0.480 |
Why?
|
Ambulatory Care | 4 | 2022 | 2782 | 0.480 |
Why?
|
Device Removal | 1 | 2020 | 635 | 0.480 |
Why?
|
Ventricular Function | 2 | 2013 | 408 | 0.470 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 594 | 0.470 |
Why?
|
Male | 65 | 2024 | 359718 | 0.470 |
Why?
|
Aortic Valve | 4 | 2013 | 1996 | 0.470 |
Why?
|
Aortic Valve Stenosis | 5 | 2020 | 2065 | 0.460 |
Why?
|
Hypolipidemic Agents | 2 | 2018 | 626 | 0.460 |
Why?
|
Pakistan | 11 | 2011 | 304 | 0.460 |
Why?
|
Health Care Sector | 1 | 2016 | 196 | 0.460 |
Why?
|
Health Status Disparities | 3 | 2021 | 1829 | 0.460 |
Why?
|
Taxes | 1 | 2016 | 222 | 0.450 |
Why?
|
Cause of Death | 7 | 2021 | 3725 | 0.440 |
Why?
|
Residence Characteristics | 2 | 2020 | 2061 | 0.430 |
Why?
|
Atrial Appendage | 2 | 2014 | 292 | 0.430 |
Why?
|
Torsades de Pointes | 1 | 2014 | 79 | 0.430 |
Why?
|
Cysts | 2 | 2018 | 683 | 0.430 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1722 | 0.430 |
Why?
|
Mentors | 1 | 2018 | 661 | 0.430 |
Why?
|
Patient Selection | 4 | 2020 | 4279 | 0.420 |
Why?
|
Language | 4 | 2022 | 1533 | 0.420 |
Why?
|
Life Expectancy | 2 | 2019 | 1247 | 0.420 |
Why?
|
Female | 60 | 2024 | 391246 | 0.410 |
Why?
|
Physicians | 3 | 2022 | 4591 | 0.410 |
Why?
|
Registries | 5 | 2020 | 8458 | 0.400 |
Why?
|
Social Behavior | 1 | 2019 | 1131 | 0.400 |
Why?
|
Biomedical Research | 3 | 2020 | 3426 | 0.400 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2014 | 124 | 0.400 |
Why?
|
Aged, 80 and over | 18 | 2024 | 58980 | 0.400 |
Why?
|
Drugs, Generic | 4 | 2023 | 448 | 0.390 |
Why?
|
Kidney Failure, Chronic | 2 | 2023 | 2470 | 0.390 |
Why?
|
Employment | 1 | 2018 | 1112 | 0.390 |
Why?
|
Treatment Refusal | 1 | 2015 | 430 | 0.390 |
Why?
|
Government Regulation | 1 | 2016 | 525 | 0.380 |
Why?
|
Echocardiography | 4 | 2020 | 4981 | 0.380 |
Why?
|
Tricuspid Valve Stenosis | 1 | 2011 | 27 | 0.380 |
Why?
|
Tachycardia, Ventricular | 1 | 2020 | 1303 | 0.380 |
Why?
|
Suicide | 1 | 2022 | 1599 | 0.380 |
Why?
|
Emotions | 2 | 2023 | 2734 | 0.380 |
Why?
|
Exercise Therapy | 1 | 2018 | 919 | 0.380 |
Why?
|
Poliovirus Vaccines | 1 | 2011 | 14 | 0.380 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 830 | 0.370 |
Why?
|
Middle Aged | 36 | 2022 | 220359 | 0.370 |
Why?
|
Developing Countries | 2 | 2023 | 2868 | 0.370 |
Why?
|
Floods | 1 | 2011 | 41 | 0.360 |
Why?
|
Hospitalization | 12 | 2023 | 10789 | 0.360 |
Why?
|
Academic Medical Centers | 2 | 2020 | 2754 | 0.360 |
Why?
|
Internet | 1 | 2022 | 3078 | 0.350 |
Why?
|
Lung Diseases | 1 | 2020 | 1915 | 0.340 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 2009 | 26 | 0.340 |
Why?
|
Tissue and Organ Procurement | 1 | 2018 | 944 | 0.340 |
Why?
|
Drug Industry | 1 | 2016 | 789 | 0.330 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2012 | 1582 | 0.330 |
Why?
|
Electrocardiography | 5 | 2014 | 6415 | 0.320 |
Why?
|
Pulmonary Edema | 1 | 2011 | 409 | 0.320 |
Why?
|
Prognosis | 6 | 2023 | 29661 | 0.320 |
Why?
|
Alzheimer Disease | 2 | 2020 | 8561 | 0.320 |
Why?
|
Patient Discharge | 2 | 2019 | 3474 | 0.310 |
Why?
|
Coronary Vessel Anomalies | 1 | 2012 | 317 | 0.310 |
Why?
|
Heart Atria | 2 | 2014 | 1346 | 0.310 |
Why?
|
Cross-Sectional Studies | 10 | 2022 | 25941 | 0.310 |
Why?
|
Islam | 1 | 2009 | 71 | 0.310 |
Why?
|
Aneurysm, False | 1 | 2011 | 257 | 0.310 |
Why?
|
Quality Improvement | 2 | 2021 | 3835 | 0.310 |
Why?
|
Tissue Donors | 1 | 2018 | 2314 | 0.310 |
Why?
|
Coronary Vessels | 3 | 2016 | 3112 | 0.310 |
Why?
|
Diabetes Complications | 1 | 2015 | 1341 | 0.300 |
Why?
|
Saphenous Vein | 1 | 2011 | 537 | 0.290 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10343 | 0.290 |
Why?
|
Thromboembolism | 1 | 2014 | 1016 | 0.290 |
Why?
|
Health Behavior | 1 | 2019 | 2622 | 0.280 |
Why?
|
Acute Coronary Syndrome | 2 | 2018 | 2365 | 0.280 |
Why?
|
Pandemics | 4 | 2023 | 8623 | 0.280 |
Why?
|
Survival Analysis | 2 | 2018 | 10185 | 0.280 |
Why?
|
Sex Factors | 3 | 2020 | 10546 | 0.270 |
Why?
|
Adult | 29 | 2023 | 220007 | 0.260 |
Why?
|
Depression | 4 | 2022 | 8045 | 0.260 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2018 | 3200 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2020 | 12289 | 0.250 |
Why?
|
Neoplasms | 4 | 2022 | 22075 | 0.250 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7475 | 0.250 |
Why?
|
Hospital Mortality | 5 | 2023 | 5418 | 0.250 |
Why?
|
Sex Distribution | 2 | 2021 | 2294 | 0.250 |
Why?
|
Diabetes Mellitus | 1 | 2023 | 5890 | 0.250 |
Why?
|
Disaster Planning | 1 | 2011 | 558 | 0.240 |
Why?
|
Cardiac Surgical Procedures | 2 | 2018 | 3620 | 0.240 |
Why?
|
Coronary Angiography | 2 | 2014 | 4563 | 0.240 |
Why?
|
Abnormalities, Multiple | 1 | 2012 | 1415 | 0.240 |
Why?
|
Age Distribution | 2 | 2021 | 2893 | 0.240 |
Why?
|
Clinical Trials as Topic | 4 | 2024 | 8055 | 0.240 |
Why?
|
Heart Transplantation | 1 | 2018 | 3224 | 0.230 |
Why?
|
Patient Readmission | 1 | 2018 | 3322 | 0.230 |
Why?
|
Decision Making | 4 | 2023 | 3925 | 0.220 |
Why?
|
Life Style | 1 | 2015 | 3898 | 0.220 |
Why?
|
Minority Groups | 2 | 2021 | 1201 | 0.220 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1921 | 0.220 |
Why?
|
Medicare | 6 | 2022 | 6785 | 0.210 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 2290 | 0.210 |
Why?
|
Atrial Fibrillation | 4 | 2021 | 5209 | 0.210 |
Why?
|
Refugees | 1 | 2011 | 598 | 0.210 |
Why?
|
Communication | 3 | 2022 | 3849 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.210 |
Why?
|
Cardiomyopathy, Hypertrophic | 2 | 2022 | 1311 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.200 |
Why?
|
Heart Rate | 1 | 2014 | 4180 | 0.200 |
Why?
|
Databases, Factual | 6 | 2020 | 8022 | 0.200 |
Why?
|
Nursing Homes | 2 | 2019 | 1082 | 0.200 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20509 | 0.190 |
Why?
|
Vaccination | 2 | 2015 | 3359 | 0.190 |
Why?
|
Coronary Artery Bypass | 1 | 2011 | 2272 | 0.190 |
Why?
|
Tax Exemption | 1 | 2020 | 15 | 0.190 |
Why?
|
Heart Ventricles | 1 | 2013 | 3812 | 0.190 |
Why?
|
Hospitals | 4 | 2023 | 3928 | 0.190 |
Why?
|
Cognition | 1 | 2018 | 6964 | 0.190 |
Why?
|
Atherosclerosis | 5 | 2018 | 3518 | 0.180 |
Why?
|
Organizations, Nonprofit | 1 | 2021 | 105 | 0.180 |
Why?
|
Cardiomyopathy, Restrictive | 1 | 2021 | 62 | 0.180 |
Why?
|
Risk Assessment | 4 | 2018 | 24102 | 0.180 |
Why?
|
Allied Health Personnel | 1 | 2022 | 156 | 0.180 |
Why?
|
Retirement | 2 | 2021 | 199 | 0.180 |
Why?
|
Cost of Illness | 3 | 2020 | 1940 | 0.180 |
Why?
|
Hospitals, Rural | 1 | 2022 | 175 | 0.180 |
Why?
|
Risk Factors | 13 | 2023 | 74333 | 0.180 |
Why?
|
Iran | 1 | 2023 | 738 | 0.180 |
Why?
|
Attitude to Health | 1 | 2009 | 2029 | 0.180 |
Why?
|
Poisson Distribution | 1 | 2021 | 507 | 0.170 |
Why?
|
Polypharmacy | 1 | 2022 | 307 | 0.170 |
Why?
|
Odds Ratio | 3 | 2020 | 9716 | 0.170 |
Why?
|
Cardiomyopathies | 2 | 2022 | 1951 | 0.170 |
Why?
|
Age Factors | 4 | 2020 | 18413 | 0.160 |
Why?
|
Puerperal Disorders | 1 | 2022 | 300 | 0.160 |
Why?
|
Chloroquine | 1 | 2020 | 277 | 0.160 |
Why?
|
Prescriptions | 1 | 2021 | 388 | 0.160 |
Why?
|
Echinococcus | 1 | 2018 | 16 | 0.160 |
Why?
|
Salaries and Fringe Benefits | 1 | 2020 | 258 | 0.160 |
Why?
|
North Carolina | 1 | 2019 | 325 | 0.150 |
Why?
|
Inpatients | 4 | 2023 | 2580 | 0.150 |
Why?
|
Intergenerational Relations | 1 | 2018 | 68 | 0.150 |
Why?
|
General Practice | 1 | 2019 | 98 | 0.150 |
Why?
|
Health Status | 4 | 2018 | 4082 | 0.150 |
Why?
|
Comorbidity | 5 | 2022 | 10553 | 0.150 |
Why?
|
Treatment Outcome | 9 | 2021 | 64981 | 0.150 |
Why?
|
Nausea | 1 | 2020 | 678 | 0.150 |
Why?
|
Retrospective Studies | 13 | 2022 | 80345 | 0.150 |
Why?
|
Ventricular Function, Left | 2 | 2022 | 3880 | 0.140 |
Why?
|
Patient Satisfaction | 2 | 2021 | 3448 | 0.140 |
Why?
|
Geography | 1 | 2019 | 661 | 0.140 |
Why?
|
Homes for the Aged | 1 | 2019 | 272 | 0.140 |
Why?
|
Independent Living | 1 | 2021 | 570 | 0.140 |
Why?
|
France | 1 | 2018 | 511 | 0.140 |
Why?
|
Fatal Outcome | 2 | 2020 | 1832 | 0.140 |
Why?
|
Incidental Findings | 2 | 2012 | 698 | 0.140 |
Why?
|
Time Factors | 7 | 2020 | 40139 | 0.140 |
Why?
|
Autopsy | 1 | 2020 | 1007 | 0.140 |
Why?
|
Absenteeism | 1 | 2018 | 250 | 0.140 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6498 | 0.140 |
Why?
|
Physician-Patient Relations | 2 | 2022 | 3242 | 0.140 |
Why?
|
Unemployment | 1 | 2018 | 209 | 0.140 |
Why?
|
Preventive Medicine | 1 | 2018 | 250 | 0.130 |
Why?
|
Coronary Disease | 1 | 2011 | 5991 | 0.130 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 427 | 0.130 |
Why?
|
Economic Competition | 1 | 2018 | 218 | 0.130 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39262 | 0.130 |
Why?
|
Biphenyl Compounds | 1 | 2020 | 992 | 0.130 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 718 | 0.130 |
Why?
|
Morbidity | 1 | 2021 | 1765 | 0.130 |
Why?
|
Politics | 1 | 2022 | 814 | 0.130 |
Why?
|
Commerce | 1 | 2020 | 605 | 0.120 |
Why?
|
Longitudinal Studies | 4 | 2018 | 14494 | 0.120 |
Why?
|
Tetrazoles | 1 | 2020 | 905 | 0.120 |
Why?
|
Drug Combinations | 1 | 2020 | 2025 | 0.120 |
Why?
|
Measles Vaccine | 1 | 2015 | 81 | 0.120 |
Why?
|
Liver Diseases | 2 | 2021 | 1302 | 0.120 |
Why?
|
User-Computer Interface | 2 | 2011 | 1403 | 0.120 |
Why?
|
Length of Stay | 4 | 2023 | 6476 | 0.110 |
Why?
|
Bacterial Infections | 2 | 2012 | 1403 | 0.110 |
Why?
|
Socioeconomic Factors | 4 | 2021 | 7805 | 0.110 |
Why?
|
Metabolic Diseases | 1 | 2020 | 685 | 0.110 |
Why?
|
Fatigue | 1 | 2020 | 1544 | 0.110 |
Why?
|
Equipment and Supplies | 1 | 2016 | 275 | 0.110 |
Why?
|
Glomerular Filtration Rate | 1 | 2022 | 2180 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2022 | 2417 | 0.110 |
Why?
|
Drug Approval | 1 | 2020 | 816 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1399 | 0.100 |
Why?
|
Canada | 1 | 2018 | 2126 | 0.100 |
Why?
|
Publishing | 1 | 2020 | 836 | 0.100 |
Why?
|
Dyspnea | 1 | 2020 | 1353 | 0.100 |
Why?
|
China | 1 | 2018 | 2339 | 0.100 |
Why?
|
Critical Illness | 2 | 2022 | 2709 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2021 | 702 | 0.100 |
Why?
|
Health Surveys | 2 | 2019 | 4063 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2018 | 1109 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2931 | 0.100 |
Why?
|
Qualitative Research | 1 | 2022 | 2963 | 0.100 |
Why?
|
Umbilicus | 1 | 2011 | 39 | 0.100 |
Why?
|
Public Policy | 1 | 2016 | 560 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 936 | 0.100 |
Why?
|
Lung Neoplasms | 1 | 2016 | 13262 | 0.090 |
Why?
|
Anticholesteremic Agents | 1 | 2018 | 987 | 0.090 |
Why?
|
Aortic Valve Insufficiency | 2 | 2012 | 584 | 0.090 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 356 | 0.090 |
Why?
|
Heart Aneurysm | 1 | 2011 | 115 | 0.090 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3149 | 0.090 |
Why?
|
Patient Admission | 1 | 2018 | 1385 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2001 | 0.090 |
Why?
|
Hematologic Neoplasms | 1 | 2022 | 1901 | 0.090 |
Why?
|
Acute Disease | 1 | 2021 | 7268 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2020 | 2061 | 0.090 |
Why?
|
Anesthesiology | 2 | 2010 | 1116 | 0.090 |
Why?
|
Hyperbilirubinemia, Neonatal | 1 | 2010 | 31 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2014 | 1578 | 0.090 |
Why?
|
Income | 1 | 2019 | 1875 | 0.090 |
Why?
|
Echocardiography, Doppler | 1 | 2014 | 901 | 0.090 |
Why?
|
Regression Analysis | 1 | 2019 | 6359 | 0.090 |
Why?
|
Soft Tissue Infections | 1 | 2011 | 168 | 0.090 |
Why?
|
Young Adult | 6 | 2022 | 58748 | 0.080 |
Why?
|
Population Surveillance | 2 | 2011 | 2608 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2021 | 1939 | 0.080 |
Why?
|
Medical Oncology | 1 | 2021 | 2313 | 0.080 |
Why?
|
Relief Work | 1 | 2011 | 128 | 0.080 |
Why?
|
Antithrombins | 1 | 2012 | 313 | 0.080 |
Why?
|
Afghanistan | 1 | 2009 | 79 | 0.080 |
Why?
|
Kidney | 2 | 2022 | 7064 | 0.080 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3442 | 0.080 |
Why?
|
Monitoring, Intraoperative | 2 | 2012 | 942 | 0.080 |
Why?
|
Systole | 1 | 2011 | 947 | 0.080 |
Why?
|
Computer Simulation | 3 | 2011 | 6218 | 0.080 |
Why?
|
Rotavirus Infections | 1 | 2009 | 85 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2022 | 3736 | 0.080 |
Why?
|
Hemorrhagic Fever, Crimean | 1 | 2008 | 7 | 0.080 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2011 | 265 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2315 | 0.080 |
Why?
|
Public Health Administration | 1 | 2011 | 243 | 0.080 |
Why?
|
Prevalence | 6 | 2021 | 15686 | 0.080 |
Why?
|
Community-Acquired Infections | 1 | 2012 | 461 | 0.080 |
Why?
|
Biopsy | 1 | 2020 | 6771 | 0.080 |
Why?
|
Adaptation, Psychological | 1 | 2019 | 2628 | 0.080 |
Why?
|
Intraoperative Care | 1 | 2012 | 768 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1570 | 0.080 |
Why?
|
Diabetic Angiopathies | 1 | 2013 | 822 | 0.070 |
Why?
|
Gastroenteritis | 1 | 2009 | 237 | 0.070 |
Why?
|
Health Care Surveys | 3 | 2022 | 2435 | 0.070 |
Why?
|
Dementia | 1 | 2022 | 2650 | 0.070 |
Why?
|
Calcinosis | 2 | 2013 | 1476 | 0.070 |
Why?
|
Heart Valve Prosthesis | 2 | 2013 | 1495 | 0.070 |
Why?
|
Survival Rate | 2 | 2020 | 12810 | 0.070 |
Why?
|
Myocardium | 1 | 2020 | 4700 | 0.070 |
Why?
|
Prospective Studies | 7 | 2019 | 54306 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2024 | 4371 | 0.070 |
Why?
|
Counseling | 1 | 2015 | 1548 | 0.070 |
Why?
|
Medicaid | 1 | 2020 | 2815 | 0.070 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1822 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1416 | 0.070 |
Why?
|
Obesity | 1 | 2009 | 12919 | 0.070 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2024 | 1031 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2165 | 0.070 |
Why?
|
Multivariate Analysis | 1 | 2019 | 12159 | 0.070 |
Why?
|
Catheterization | 1 | 2011 | 1432 | 0.070 |
Why?
|
Infant, Newborn | 5 | 2020 | 26179 | 0.060 |
Why?
|
Logistic Models | 1 | 2020 | 13312 | 0.060 |
Why?
|
Neonatal Screening | 1 | 2010 | 595 | 0.060 |
Why?
|
Thinness | 1 | 2009 | 491 | 0.060 |
Why?
|
Psoriasis | 1 | 2013 | 940 | 0.060 |
Why?
|
Infant | 6 | 2020 | 36053 | 0.060 |
Why?
|
Child, Preschool | 4 | 2020 | 42056 | 0.060 |
Why?
|
Incidence | 4 | 2018 | 21391 | 0.060 |
Why?
|
International Cooperation | 1 | 2011 | 1433 | 0.060 |
Why?
|
Anesthesia, General | 1 | 2011 | 1166 | 0.060 |
Why?
|
Child | 5 | 2021 | 79799 | 0.060 |
Why?
|
Adolescent | 6 | 2022 | 87809 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4446 | 0.060 |
Why?
|
Vascular Surgical Procedures | 1 | 2012 | 1469 | 0.050 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 5508 | 0.050 |
Why?
|
Ultrasonography | 2 | 2013 | 5961 | 0.050 |
Why?
|
Skin Diseases | 1 | 2011 | 1089 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5325 | 0.050 |
Why?
|
Teaching | 1 | 2010 | 1169 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2022 | 6659 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2011 | 1204 | 0.050 |
Why?
|
Body Height | 1 | 2009 | 1570 | 0.050 |
Why?
|
Malnutrition | 1 | 2009 | 640 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13505 | 0.050 |
Why?
|
Kansas | 1 | 2021 | 38 | 0.050 |
Why?
|
Body Mass Index | 1 | 2019 | 12914 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15840 | 0.050 |
Why?
|
Parents | 1 | 2015 | 3549 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1860 | 0.050 |
Why?
|
Bacteria | 1 | 2011 | 2199 | 0.050 |
Why?
|
Peripartum Period | 1 | 2022 | 138 | 0.050 |
Why?
|
Reoperation | 1 | 2011 | 4289 | 0.040 |
Why?
|
Software | 2 | 2011 | 4419 | 0.040 |
Why?
|
Homosexuality, Male | 1 | 2008 | 1273 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2011 | 8950 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3985 | 0.040 |
Why?
|
Schools | 1 | 2009 | 1480 | 0.040 |
Why?
|
Social Class | 1 | 2009 | 2005 | 0.040 |
Why?
|
Calcium | 1 | 2013 | 5725 | 0.040 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2021 | 192 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2011 | 12968 | 0.040 |
Why?
|
Journal Impact Factor | 1 | 2020 | 156 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2007 | 2197 | 0.040 |
Why?
|
Body Weight | 1 | 2009 | 4611 | 0.040 |
Why?
|
Sepsis | 1 | 2012 | 2592 | 0.040 |
Why?
|
Cardiovascular Agents | 1 | 2024 | 866 | 0.040 |
Why?
|
Drug Prescriptions | 2 | 2018 | 1673 | 0.040 |
Why?
|
Thrombosis | 1 | 2012 | 3051 | 0.040 |
Why?
|
Mass Screening | 1 | 2013 | 5422 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2012 | 7408 | 0.030 |
Why?
|
Phenotype | 1 | 2014 | 16548 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2022 | 1259 | 0.030 |
Why?
|
Demography | 1 | 2020 | 1650 | 0.030 |
Why?
|
Housing | 1 | 2020 | 665 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 1523 | 0.030 |
Why?
|
Clinical Competence | 1 | 2010 | 4783 | 0.030 |
Why?
|
Psychotherapy | 1 | 2022 | 1640 | 0.030 |
Why?
|
Cost Savings | 1 | 2018 | 920 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2018 | 843 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2012 | 516 | 0.020 |
Why?
|
Gentamicins | 1 | 2012 | 252 | 0.020 |
Why?
|
Ceftriaxone | 1 | 2012 | 176 | 0.020 |
Why?
|
Diet | 1 | 2009 | 8010 | 0.020 |
Why?
|
Atrial Septum | 1 | 2011 | 61 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2014 | 585 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2020 | 1200 | 0.020 |
Why?
|
Cholelithiasis | 1 | 2012 | 408 | 0.020 |
Why?
|
Internship and Residency | 1 | 2010 | 5870 | 0.020 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7818 | 0.020 |
Why?
|
Animals | 3 | 2018 | 167960 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2013 | 951 | 0.020 |
Why?
|
Penicillins | 1 | 2012 | 407 | 0.020 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1469 | 0.020 |
Why?
|
Computer Graphics | 1 | 2010 | 341 | 0.020 |
Why?
|
Rotavirus | 1 | 2009 | 110 | 0.020 |
Why?
|
Poverty | 1 | 2020 | 2695 | 0.020 |
Why?
|
Bilirubin | 1 | 2010 | 438 | 0.020 |
Why?
|
Immunization Schedule | 1 | 2009 | 224 | 0.020 |
Why?
|
Sexual Behavior | 2 | 2008 | 2086 | 0.020 |
Why?
|
Aneurysm | 1 | 2011 | 337 | 0.020 |
Why?
|
Urban Health | 1 | 2010 | 533 | 0.020 |
Why?
|
Coronary Circulation | 1 | 2013 | 1577 | 0.020 |
Why?
|
Cardiopulmonary Bypass | 1 | 2012 | 1096 | 0.020 |
Why?
|
Hemangioma | 1 | 2012 | 728 | 0.020 |
Why?
|
Bisexuality | 1 | 2008 | 274 | 0.020 |
Why?
|
Ribavirin | 1 | 2008 | 396 | 0.020 |
Why?
|
Polysaccharides | 1 | 2012 | 1016 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2129 | 0.020 |
Why?
|
India | 1 | 2012 | 2336 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8556 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2011 | 1949 | 0.020 |
Why?
|
Heparin | 1 | 2012 | 1652 | 0.020 |
Why?
|
Aspirin | 1 | 2017 | 3364 | 0.020 |
Why?
|
Cohort Studies | 3 | 2012 | 41337 | 0.010 |
Why?
|
Outpatients | 1 | 2012 | 1607 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2362 | 0.010 |
Why?
|
Diarrhea | 1 | 2009 | 1319 | 0.010 |
Why?
|
Risk-Taking | 1 | 2008 | 998 | 0.010 |
Why?
|
Mental Health | 1 | 2017 | 3213 | 0.010 |
Why?
|
Substance Abuse, Intravenous | 1 | 2007 | 530 | 0.010 |
Why?
|
HIV Infections | 1 | 2008 | 17165 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9632 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2008 | 1328 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2659 | 0.010 |
Why?
|
Communicable Disease Control | 1 | 2007 | 844 | 0.010 |
Why?
|
Heart | 1 | 2010 | 4393 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14661 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15286 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2008 | 3061 | 0.010 |
Why?
|
Genotype | 1 | 2009 | 12957 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20080 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10755 | 0.010 |
Why?
|
HIV-1 | 1 | 2008 | 6849 | 0.010 |
Why?
|
Pregnancy | 1 | 2010 | 29746 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2012 | 36286 | 0.000 |
Why?
|